Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Auditor change
|
|
Inhibitor Therapeutics, Inc. (HPPI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/30/2014 |
8-K
| Appointed a new director|
Docs:
|
"Warrant, issued to Mayne Pharma Ventures Pty Ltd",
"Warrant, issued to Hedgepath, LLC",
"Securities Purchase Agreement, by and between HedgePath Pharmaceuticals, Inc. and Mayne Pharma Ventures Pty Ltd",
"Stock Purchase Agreement, by and between HedgePath Pharmaceuticals, Inc. and Hedgepath, LLC",
"Promissory Note, issued to HedgePath Pharmaceuticals, Inc",
"Equity Holders Agreement, by and between HedgePath Pharmaceuticals, Inc., Mayne Pharma Ventures Pty Ltd., Hedgepath, LLC, Nicholas J. Virca and Frank O'Donnell, Jr. M.D. (*)",
"Debt Forgiveness Agreement, by and between HedgePath Pharmaceuticals, Inc. and Hedgepath, LLC",
"Employment Agreement, with Nicholas J. Virca (*)",
"Executive Chairman Agreement, with Frank O'Donnell, Jr. M.D",
"Amended and Restated Supply and License Agreement, by and between HedgePath Pharmaceuticals, Inc. and Mayne Pharma Ventures Pty Ltd.(*)" |
|
| 02/15/2007 |
8-K
| Form 8-K - Current report |
| 11/29/2006 |
8-K
| Form 8-K - Current report |
|
|